(Q49142255)

18 February 2018

title

Molecular genetics of radiographically defined de novo glioblastoma multiforme. (English)

1 reference

18 February 2018

1 reference

1 reference

1

1 reference

18 February 2018

author name string

Y Ino

2

1 reference

18 February 2018

N Odell

3

1 reference

18 February 2018

S Swilley

4

1 reference

18 February 2018

H Sasaki

5

1 reference

18 February 2018

D N Louis

6

1 reference

18 February 2018

J W Henson

7

1 reference

18 February 2018

publication date

1 December 2000

1 reference

18 February 2018

Neuropathology and Applied Neurobiology

published in

1 reference

18 February 2018

volume

26

1 reference

18 February 2018

page(s)

544-552

1 reference

18 February 2018

issue

6

1 reference

18 February 2018

Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

PTEN mutations in gliomas and glioneuronal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

The new WHO classification of brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

A molecular genetic model of astrocytoma histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

A tiger behind many doors: multiple genetic pathways to malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

Genetic alterations associated with the evolution and progression of astrocytic brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

Age-dependent rate of anaplastic transformation in low-grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

Subsets of glioblastoma multiforme defined by molecular genetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2000.00290.X

10.1046/J.0305-1846.2000.00290.X

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

11123721

1 reference

18 February 2018